Skip to main content
. 2020 Jul 13;67(3):362–368. doi: 10.1016/j.jadohealth.2020.06.025

Table 3.

Young adult COVID-19 individual medical vulnerability conditions, ages 18–25 years, rates and differences NHIS 2016–2018

Asthma (current), % (N) 95% CI Heart condition, % (N) 95% CI Immune conditionb, % (N) 95% CI Diabetes, % (N) 95% CI Liver condition, % (N) 95% CI BMI ≥40 kg/m2, % (N) 95% CI
Full sample 8.6 (760) .5 (34) 2.4 (212) 1.2 (101) .6 (45) 3.0 (240)
Sex
 Female 10.0 (443) .5 (16) 3.2 (144) 1.2 (58) .6 (20) 3.3 (149)
1.1–1.7∗a 1.4–3.2∗∗ .6–1.8 .9–1.8
 MaleRef 7.3 (317) .6 (18) 1.6 (68) 1.1 (43) .6 (25) 2.6 (91)
Race/ethnicity
 NH whiteRef 9.2 (474) .5 (18) 3.1 (154) 1.1 (60) .5 (26) 2.7 (132)
 NH black 11.0 (108) .4 (3) 1.4 (18) 1.4 (15) .3 (2) 4.4 (44)
.9–1.6 1.1–2.7
 Hispanic 6.2 (108) .5 (9) 1.3 (21) 1.1 (15) 1.1 (15) 2.9 (44)
.5–.9∗ .7–1.7
 NH Asian 4.3 (21) .1 (1) 1.0 (3) .3 (3) .1 (2) .5 (2)
-- --
 NH other 13.2 (49) 1.5 (3) 4.9 (16) 2.8 (8) 0 (0) 5.5 (18)
1.0–2.3 --
Income category
 <100% FPL 10.7 (300) .6 (10) 2.5 (68) 1.7 (46) .6 (14) 3.2 (79)
1.0–1.8 .8–2.4 .9–2.7
 100%–<200% FPL 8.6 (166) .6 (9) 2.6 (51) 1.4 (22) .4 (6) 3.6 (56)
.8–1.4 .8–2.7 1.0–3.1
 200%–<400% FPL 7.6 (165) .5 (8) 2.8 (61) 1.1 (24) .6 (13) 3.1 (71)
.7–1.2 .9–2.7 .9–2.5
 ≥400% FPLRef 8.1 (129) .5 (7) 1.8 (31) .7 (8) .7 (11) 2.1 (34)
Insurance status
 Full-year insuredRef 8.8 (623) .5 (26) 2.5 (172) 1.1 (73) .5 (32) 2.5 (172)
 Partial-year uninsured 10.5 (85) .5 (4) 2.2 (22) 2.4 (21) 1.1 (8) 4.5 (40)
.9–1.6 1.2–2.9∗
 Full-year uninsured 5.1 (33) .9 (4) 1.6 (15) 1.1 (6) .8 (4) 3.4 (17)
.4–.9 --

Ref indicates referent group.

Italicized estimates and % indicate rate are not reliable because relative standard error (RSE) exceeds 25%, and bolded values highlight significant differences.

COVID-19 = coronavirus disease 2019; FPL = Federal Poverty Level; NH = non-Hispanic; NHIS: National Health Interview Survey.

a

Significance and 95% confidence levels based on odds ratios; ∗p < .01, ∗∗p < .001.

b

Composite of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.